Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05678608
Other study ID # soh-med-22-12-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 13, 2022
Est. completion date May 2023

Study information

Verified date December 2022
Source Sohag University
Contact mohamed M kassem, demonstrator
Phone 010980-03153
Email mohamed011152@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Primary spinal cord tumors constitute 2-4% of all central nervous system neoplasms; they are classfied as extradural, intradural extramedullary (IDEM: 65%), and intramedullary The most commonly seen IDEM tumors are schwannomas, neurofibromas, and meningiomas. [1] The less frequently encountered IDEM tumors include ependymomas, lipomas, hemangiomas, metastatic deposits, paragangliomas, nerve sheath myxomas, and vascular tumors.[2] Spinal cord tumors can cause different signs and symptoms, especially as tumors grow. The tumors may affect spinal cord or the nerve roots, blood vessels or bones of spine. Signs and symptoms may include: Pain at the site of the tumor due to tumor growth Back pain, often radiating to other parts of body Feeling less sensitive to pain, heat and cold Loss of bowel or bladder function Difficulty walking, muscle weakness . MRI is the investigation of choice,however other investigation such CT or X ray are important to ensure stability of the vertebral column and the optimal management is gross total excision for symptomatic lesions.[3,4] Over the years, there has been no significant change in the clinical symptoms and pathology of IDEM tumors. However, there have been dramatic improvements in the diagnosis and treatment with the advances of radiological and surgical techniques. Despite advances in operative techniques and neuroimaging, the morbidity associated with the resection of IDEM tumors continues to be significant [5,6]. Here, we examined the surgical outcomes of 20 patients with IDEM spinal cord tumors operated in Neurosurgery department at Sohag university Hospital


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date May 2023
Est. primary completion date May 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients with intradural extramedullary lesion in dorsolumber region Exclusion Criteria: - previous history of spinal surgery - unfit medical patients - multiple level affection - associated cervical lesion - unstable segment

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
surgical excision
posterior midline approach and total excision for spinal cord tumors

Locations

Country Name City State
Egypt Sohag University Hospital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: current classification and MRI features. Neuroradiology. 2008 Apr;50(4):301-14. doi: 10.1007/s00234-007-0345-7. Epub 2007 Dec 15. — View Citation

Narayan S, Rege SV, Gupta R. Clinicopathological Study of Intradural Extramedullary Spinal Tumors and Its Correlation With Functional Outcome. Cureus. 2021 Jun 18;13(6):e15733. doi: 10.7759/cureus.15733. eCollection 2021 Jun. — View Citation

Song KW, Shin SI, Lee JY, Kim GL, Hyun YS, Park DY. Surgical results of intradural extramedullary tumors. Clin Orthop Surg. 2009 Jun;1(2):74-80. doi: 10.4055/cios.2009.1.2.74. Epub 2009 May 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary american spinal injury association scale grading of impairment for motor and sensory functions grade A for complete sensory and motor loss grade E for normal motor and sensory 6 months
Primary visual analogue pain scale pain scale from zero to ten depend on severity of pain, 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05023772 - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases N/A
Not yet recruiting NCT06357377 - A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors Phase 1
Completed NCT00430872 - Development of the MDASI-Spine Tumor Module N/A
Completed NCT04331431 - Outcomes of the Intradural Extramedullary Tumors Resection N/A